Tag: Collaboration
Lifebit and Boehringer Ingelheim Partner Up to Maximize the Value of Biobank Data for...
Computational science is revolutionizing the world in many ways. Hundreds of new fields and disciplines have emerged with countless opportunities and possibilities. The digital revolution has reached all sectors of modern society, including biomedical research and health care. Almost...
Datavant Partners with Nashville Biosciences to Accelerate Drug Discovery and Clinical Research
Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC) that leverages BioVU®, the medical center’s de-identified biobank to support biopharma research and development, and Datavant, the leader in securely connecting the world’s health data, today announced a...
Syntegra Partners with Nashville Biosciences on Biobank Data Analysis for Drug R&D
Syntegra and Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), just announced a collaboration to accelerate data driven innovation and research for drug discovery and development.
Nashville Biosciences was created to facilitate commercial R&D uses of...
What can Biobanks Learn From the Current Pandemic?
More than a year ago, something happened that most of us could hardly imagine. A virus took the whole world more or less firmly in its grip. Pandemic, previously a word that very few of us knew, has now...
EU-CardioRNA COST Action Meetings Report Released
The European Cooperation in Science and Technology (COST Association) runs an EU-funded programme that encourages researchers and innovators to create research networks called COST Actions. The EU-CardioRNA COST Action, launched in 2018, is intended to promote transcriptomics research in...
Centogene And PTC Therapeutics Collaborate To Deliver A Diagnostic Program For AADC Deficiency
CENTOGENE N.V., a commercial-stage company focused on rare
diseases that transforms real-world clinical and genetic data into actionable
information for patients, physicians and pharmaceutical companies, has signed
an agreement with PTC Therapeutics, Inc. (PTC) for a global diagnostic program
for aromatic L-amino acid...
CENTOGENE And Pfizer Collaborating For Rare Disease Patients
CENTOGENE, a commercial-stage company focused on rare
diseases that transforms real-world clinical and genetic data into actionable
information for patients, physicians and pharmaceutical companies, has a new
data access and collaboration agreement with Pfizer Inc. The agreement grants
Pfizer access to CENTOGENE’s data...
Owlstone Medical Joins 3TR To Provide Breath Biopsy Infrastructure And Analysis For Multiple Studies
Owlstone Medical, the global leader in Breath Biopsy® for
applications in early disease detection and precision medicine has joined 3TR,
a large-scale public-private research initiative that aims to provide new
insights into the mechanisms of response and non-response to treatment within
and across...
The Thailand CELS And PhenoMx Sign MOU With Potential Biobanking Projects
The Thailand Center of Excellence for Life Sciences (TCELS),
a public organisation, and PhenoMx, Inc., a US-based health technology company,
announced the execution of a Memorandum of Understanding (MOU) to develop
strategic initiatives for Thailand in the biomedical, life science and medical
device...
4D Pharma And MSD Collaborate Leveraging The Microbiome To Develop Live Biotherapeutic Vaccines
4D pharma plc, a pharmaceutical company leading the
development of Live Biotherapeutics, has entered into a research collaboration
and option to license agreement with MSD, the tradename of Merck & Co.,
Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics
("LBPs") for...
